Synthesis and evaluation of smart drugs with integrated functions for identifying and treating oxidative microenvironments associated with cellular ferroptosis

Yibo Zhang , Rui Cai , Yu Ding , Jiangye Zhang , Changxu Ning , Jiangcheng Zeng , Zhongxiang Zhou , Shisheng Wang , Yueqing Li , Xiuhan Guo

Smart Molecules ›› 2025, Vol. 3 ›› Issue (2) : e20240048

PDF
Smart Molecules ›› 2025, Vol. 3 ›› Issue (2) : e20240048 DOI: 10.1002/smo.20240048
RESEARCH ARTICLE

Synthesis and evaluation of smart drugs with integrated functions for identifying and treating oxidative microenvironments associated with cellular ferroptosis

Author information +
History +
PDF

Abstract

Ferroptosis is a novel form of cell death driven by oxidative damage, and is implicated in various pathological conditions, including neurodegenerative diseases, retinal damage, and ischemia-reperfusion injury of organs. Inhibiting ferroptosis has shown great promise as a therapeutic strategy for these diseases, underscoring the urgent need to develop effective ferroptosis inhibitors. Although Ferrostatin-1 (Fer-1) is a potent ferroptosis inhibitor, its susceptibility to oxidation and metabolic inactivation limits its clinical utility. In this study, the accumulation of peroxides and the resulting oxidative damage in the cellular microenvironment during ferroptosis were utilized to design Ferrostatin-1 prodrugs with reactive oxygen species-responsive features. This approach led to the development of a series of ferroptosis inhibitors that were capable of recognizing oxidative damage in diseased areas, allowing for targeted release and improved stability. The novel compounds demonstrated significant inhibitory effects and selectivity against RSL-3-induced ferroptosis in HK-2 cells, with compound a1 exhibiting an EC50 of 15.4 ± 0.7 μM, outperforming Fer-1. These compounds effectively identify the oxidative microenvironment associated with ferroptosis, enabling the targeted release of Fer-1, which prevents lipid peroxide accumulation and inhibits ferroptosis. This strategy holds promise for treating diseases related to ferroptosis, offering a targeted and intelligent therapeutic approach.

Keywords

ferroptosis inhibitor / oxidative microenvironment / recognizing / space-time controlled release

Cite this article

Download citation ▾
Yibo Zhang, Rui Cai, Yu Ding, Jiangye Zhang, Changxu Ning, Jiangcheng Zeng, Zhongxiang Zhou, Shisheng Wang, Yueqing Li, Xiuhan Guo. Synthesis and evaluation of smart drugs with integrated functions for identifying and treating oxidative microenvironments associated with cellular ferroptosis. Smart Molecules, 2025, 3(2): e20240048 DOI:10.1002/smo.20240048

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

S. J. Dixon, K. M. Lemberg, M. R. Lamprecht, R. Skouta, E. M. Zaitsev, C. E. Gleason, D. N. Patel, A. J. Bauer, A. M. Cantley, W. S. Yang, B. Morrison, , B. Stockwell, Cell 2012, 149, 1060, Article

[2]

B. R. Stockwell, J. P. F. Angeli, H. Bayir, A. I. Bush, M. Conrad, S. J. Dixon, S. Fulda, S. Gascon, S. K. Hatzios, V. E. Kagan, K. Noel, X. Jiang, A. Linkermann, M. E. Murphy, M. Overholtzer, A. Oyagi, G. C. Pagnussat, J. Park, Q. Ran, C. S. Rosenfeld, K. Salnikow, D. Tang, F. M. Torti, S. V. Torti, S. Toyokuni, K. Woerpel, D. D. Zhang, Cell 2017, 171, 273, Review

[3]

S. J. Dixon, B. R. Stockwell, Nat. Chem. Biol. 2014, 10, 9

[4]

B. R. Stockwell, X. Jiang, Cell Chem. Biol. 2020, 27, 365.

[5]

G. Lei, L. Zhuang, B. Gan, Nat. Rev. Cancer 2022, 22, 381, Review.

[6]

Y. Gu, Y. Li, J. Wang, L. Zhang, J. Zhang, Y. Wang, Eur. J. Med. Chem. 2023, 247, Review.

[7]

Z. Bao, Y. Liu, B. Chen, Z. Miao, Y. Tu, C. Li, H. Chao, Y. Ye, X. Xu, G. Sun, P. Zhao, N. Liu, X. Wang, S. M. Lam, V. E. Kagan, H. Bayır, J. Ji, Nat. Commun. 2021, 12, Article.

[8]

Y. Cheng, W. Qu, J. Li, B. Jia, Y. Song, L. Wang, T. Rui, Q. Li, C. Luo, ACS Chem. Neurosci. 2022, 13, 664, Article.

[9]

Y. Wang, M. N. Lv, W. J. Zhao, Ageing Res. Rev. 2023, 91, Review.

[10]

Q. Wang, J. Sun, T. Chen, S. Song, Y. Hou, L. Feng, C. Fan, M. Li, ACS Chem. Neurosci. 2023, 14, 3564, Review.

[11]

L. L. Chen, Y. G. Fan, L. X. Zhao, Q. Z. ZhanYou, Z. Y. Wang, Bioorg. Chem. 2023, 131, Review.

[12]

J. Liu, C. Huang, J. Liu, C. Meng, Q. Gu, X. Du, M. Yan, Y. Yu, F. Liu, C. Xia, Pharmacol. Res. 2023, 187, Article.

[13]

L. Ni, C. Yuan, X. Wu, Cell Death Dis. 2022, 13, Article.

[14]

J. Chen, X. Li, C. Ge, J. Min, F. Wang, Cell Death Differ. 2022, 29, 467, Review.

[15]

W. Cai, L. Liu, X. Shi, Y. Liu, J. Wang, X. Fang, Z. Chen, D. Ai, Y. Zhu, X. Zhang, Circulation 2023, 147, 1444, Article.

[16]

Y. Jin, Y. Zhuang, M. Liu, J. Che, X. Dong, Drug Discov. Today 2021, 26, 916, Review.

[17]

B. Dong, C. Ding, H. Xiang, J. Zheng, X. Li, W. Xue, Y. Li, Inflamm. Res. 2022, 71, 1519, Article.

[18]

M. Conrad, S. M. Lorenz, B. Proneth, Trends Mol. Med. 2021, 27, 113, Review.

[19]

L. Huo, C. Liu, Y. Yuan, X. Liu, Q. Cao, Eur. J. Med. Chem. 2023, 257, 115438, Review.

[20]

C. Li, Y. Wu, K. Chen, R. Chen, S. Xu, B. Yang, Z. Lian, X. Wang, K. Wang, H. Xie, S. Zheng, Z. Liu, D. Wang, X. Xu, Cell Death Dis. 2023, 14, 810, Article.

[21]

Y. Zhang, H. Wei, M. Wang, Y. Yu, M. Gu, H. Zhong, S. Dong, Biomed. Pharmacother. 2023, 169, 115915, Article.

[22]

R. Skouta, S. J. Dixon, J. Wang, D. E. Dunn, M. Orman, K. Shimada, P. A. Rosenberg, D. C. Lo, J. M. Weinberg, A. Linkermann, B. R. Stockwell, J. Am. Chem. Soc. 2014, 136, 4551, Article.

[23]

O. Zilka, R. Shah, B. Li, J. P. F. Angeli, M. Griesser, M. Conrad, D. A. Pratt, ACS Cent. Sci. 2017, 3, 232, Article.

[24]

L. A. Farmer, Z. Wu, J.-F. Poon, O. Zilka, S. M. Lorenz, S. Huehn, B. Proneth, M. Conrad, D. A. Pratt, J. Am. Chem. Soc. 2022, 144, 14706, Article.

[25]

Minami, J. K.; Morrow, D.; Bayley, N. A.; Fernandez, E. G.; Salinas, J. J.; Tse, C.; Zhu, H.; Su, B.; Plawat, R.; Jones, A., Sammarco, A., Liau, L. M., Graeber, T. G., Williams, K. J., Cloughesy, T. F., Dixon, S. J., Bensinger, S. J., Nathanson, D. A. Cancer Cell 2023, 41, 1048, Article.

[26]

L. Devisscher, S. Van Coillie, S. Hofmans, D. Van Rompaey, K. Goossens, E. Meul, L. Maes, H. De Winter, P. Van Der Veken, P. Vandenabeele, T. V. Berghe, K. Augustyns, J. Med. Chem. 2018, 61, 10126, Article.

[27]

S. Hofmans, T. Vanden Berghe, L. Devisscher, B. Hassannia, S. Lyssens, J. Joossens, P. Van Der Veken, P. Vandenabeele, K. Augustyns, J. Med. Chem. 2016, 59, 2041, Article.

[28]

C. Scarpellini, G. Klejborowska, C. Lanthier, B. Hassannia, T. Vanden Berghe, K. Augustyns, Trends Pharmacol. Sci. 2023, 44, 902, Review.

[29]

M. M. Gaschler, F. Hu, H. Feng, A. Linkermann, W. Min, B. R. Stockwell, ACS Chem. Biol. 2018, 13, 1013, Article

[30]

X. X. Wang, R. J. Wang, H. L. Ji, X. Y. Liu, N. Y. Zhang, K. M. Wang, K. Chen, P. P. Liu, N. Meng, C. S. Jiang, RSC Med. Chem. 2024, 15, 1198, Article.

[31]

H. L. Ji, Y. F. Zhang, N. Y. Zhang, K. M. Wang, N. Meng, J. Zhang, C. S. Jiang, Biorg. Med. Chem. 2024, 105, 117716.

[32]

Y. H. Chen, W. He, H. Wei, C. C. Chang, L. J. Yang, J. Meng, T. L. Long, Q. H. Xu, C. Zhang, CNS Neurosci. Ther. 2023, 29, 1667.

[33]

A. Bedini, A. Fraternale, R. Crinelli, M. Mari, S. Bartolucci, L. Chiarantini, G. Spadoni, Chem. Res. Toxicol. 2019, 32, 100, Article.

[34]

E. D. Farfan-Garcia, N. T. Castillo-Mendieta, F. J. Cipres-Floresa, I. I. Padilla-Martinez, J. G. Trujillo-Ferrara, M. A. Soriano-Ursua, Toxicol. Lett. 2016, 258, 115, Article.

RIGHTS & PERMISSIONS

2024 The Author(s). Smart Molecules published by John Wiley & Sons Australia, Ltd on behalf of Dalian University of Technology.

AI Summary AI Mindmap
PDF

19

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/